Tag: insightec

FDA approves pivotal study of Exablate Neuro for treatment of Parkinson’s...

INSIGHTEC has received approval from the US Food and Drug Administration (FDA) to initiate a pivotal study of the Exablate Neuro for treating dyskinesia...

First Alzheimer’s trial with focused ultrasound begins

Researchers at Sunnybrook Health Sciences Centre in Toronto, Canada have begun the world’s first clinical trial evaluating the feasibility and safety of opening the...

The Japanese Ministry of Health, Labour and Welfare approves Exablate Neuro...

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved InSightec’s Exablate Neuro system for the non-invasive treatment of essential tremor in patients...

Siemens and InSightec sign strategic agreement to develop compatibility between some...

InSightec has signed a strategic agreement with Siemens Healthineers. The strategic collaboration will involve the development of compatibility between Exablate Neuro and Siemens 1.5T...

InSightec Exablate coverage expands to 99.8million US individuals

  Coverage for Exablate (InSightec) for pain palliation of bone metastases in cancer patients has expanded for members of a major health insurance provider in...

FDA approves first MRI-guided focused ultrasound device to treat essential tremor

The US Food and Drug Administration has approved the first focused ultrasound device to treat essential tremor in patients who have not responded to...

Health Canada approves Insightec’s Exablate Neuro system for the treatment of...

INSIGHTEC has announced that Health Canada has approved its Exablate Neuro system for the treatment of essential tremor. INSIGHTEC’s Exablate Neuro platform is transforming medicine...

Insightec broadcasts the first live Exablate Neuro brain treatment at ISTU...

At the 16th International Symposium on Therapeutic Ultrasound 2016 (ISTU) in Tel Aviv, Israel, INSIGHTEC hosted a first time live broadcast from the MRI room...

InSightec secures US$22 million and appoints Maurice R Ferré as chief...

InSightec has secured a US$22 million as part of its round D investment. This investment has been led by its current shareholders. In addition,...

Exablate Neuro platform approved by Korean Ministry of Food and Drug...

Elbit Imaging, a shareholder in InSightec, has announced that the company’s Exablate Neuro platform has been approved for the treatment of movement, pain and...

Insightec submits pre-market application for FDA approval of Exablate Neuro for...

Insightec has announced that it has submitted a pre-market approval application (PMA) to the US Food and Drug Administration (FDA) for its Exablate Neuro...

Insightec announces launch of Neurosurgery System on 1.5T MRI platform

Insightec has expanded its non-invasive neurosurgery system from 3T to 1.5T magnetic resonance imaging (MRI) systems. This launch expands the potential market for Insightec’s ExAblate...